"Our expert cardiologists provide services like angioplasty, echocardiograms, stress tests, pacemaker implants and much more."

During the past decade, Northern Utah Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 16 clinical trials were completed, i.e. on average, 228.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Utah Associates" #1 sponsor was "Genentech, Inc." with 7 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Celgene" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Millennium Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Utah Associates" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Northern Utah Associates" are "Breast Cancer" (9 trials), "Multiple Myeloma" (5 trials), "Colorectal Cancer" (4 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Northern Utah Associates" in a lesser frequency.

Most popular intervention types in "Northern Utah Associates" are "Drug" (32 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (5 trials), "Paclitaxel" (5 trials), "Placebo" (5 trials), "Dexamethasone" (4 trials) and "Elotuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Northern Utah Associates" are 25 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northern Utah Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Northern Utah Associates, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Utah Associates, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".